Main > > >NEUROMUSCULAR.

Non-Dystrophic Myotonic (NDM) Disorders.
Myotonia. TREAT.: Mexiletine.
DE Launch Date: 2019. 02.01.
EU Approval Date: 2018. 12.
UK Launch Date: 2019. 02.01.
(*) Company (DE): Hormosan Pharma GmbH.<
Lupin Ltd.
(*) Company (UK): Lupin Healthcare (UK)
Ltd.
(*) TradeMark : NaMuscla
UpDate: 2019. 02.02.



>NEUROMUSCULAR.'s products
This section has no products